CI
ALXN

Conning Inc’s Alexion Pharmaceuticals ALXN Stock Holding History

Conning Inc’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,592
Closed -$476K – 494
2021
Q2 		$476K Sell
2,592
-258
-9% -$44.3K 0.01% 289
2021
Q1 		$436K Sell
2,850
-270
-9% -$41.8K 0.01% 310
2020
Q4 		$487K Sell
3,120
-129
-4% -$16.6K 0.02% 288
2020
Q3 		$372K Buy
3,249
+20
+0.6% +$2.16K 0.01% 320
2020
Q2 		$362K Buy
3,229
+1
+0% +$106 0.01% 310
2020
Q1 		$290K Sell
3,228
-103
-3% -$10.1K 0.01% 321
2019
Q4 		$360K Buy
3,331
+50
+2% +$5.35K 0.01% 345
2019
Q3 		$321K Sell
3,281
-109
-3% -$12.3K 0.01% 386
2019
Q2 		$444K Sell
3,390
-610
-15% -$78.6K 0.01% 327
2019
Q1 		$541K Buy
4,000
+40
+1% +$4.97K 0.02% 331
2018
Q4 		$386K Sell
3,960
-940
-19% -$111K 0.01% 379
2018
Q3 		$681K Sell
4,900
-390
-7% -$48.9K 0.02% 321
2018
Q2 		$657K Sell
5,290
-90
-2% -$10.5K 0.02% 338
2018
Q1 		$600K Buy
5,380
+250
+5% +$29.9K 0.02% 349
2017
Q4 		$613K Sell
5,130
-290
-5% -$35.3K 0.02% 363
2017
Q3 		$760K Sell
5,420
-350
-6% -$47.6K 0.03% 317
2017
Q2 		$702K Sell
5,770
-40
-0.7% -$4.66K 0.03% 336
2017
Q1 		$704K Sell
5,810
-120
-2% -$15.5K 0.03% 329
2016
Q4 		$726K Buy
5,930
+390
+7% +$47.7K 0.03% 320
2016
Q3 		$679K Buy
5,540
+150
+3% +$19.3K 0.03% 325
2016
Q2 		$629K Buy
5,390
+10
+0.2% +$1.42K 0.03% 327
2016
Q1 		$749K Buy
5,380
+10
+0.2% +$1.47K 0.03% 294
2015
Q4 		$1.02M Sell
5,370
-220
-4% -$38.4K 0.04% 253
2015
Q3 		$874K Sell
5,590
-370
-6% -$67.5K 0.04% 262
2015
Q2 		$1.08M Buy
5,960
+220
+4% +$38K 0.04% 256
2015
Q1 		$995K Hold
5,740
– – 0.04% 250
2014
Q4 		$1.06M Sell
5,740
-140
-2% -$25.9K 0.05% 234
2014
Q3 		$975K Buy
5,880
+670
+13% +$110K 0.05% 242
2014
Q2 		$814K Sell
5,210
-300
-5% -$47.4K 0.04% 274
2014
Q1 		$838K Buy
5,510
+340
+7% +$54.1K 0.05% 262
2013
Q4 		$688K Buy
5,170
+1,020
+25% +$122K 0.04% 269
2013
Q3 		$482K Buy
4,150
+520
+14% +$57.1K 0.04% 297
2013
Q2 		$335K Buy
+3,630
New +$350K 0.03% 352

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return